Why the study?
Although electrocardiography and cardiac troponin are important in diagnosing ACS, unmet clinical needs remain, prompting evaluation of H-FABP as an early diagnostic and prognostic marker.
Does H-FABP measurement improve the early diagnostic accuracy for acute myocardial infarction in adults presenting to the ER with chest pain or dyspnea compared to traditional cardiac markers?
Does H-FABP measurement improve the early diagnostic accuracy for acute myocardial infarction in adults presenting to the ER with chest pain or dyspnea compared to traditional cardiac markers?
H-FABP demonstrates higher diagnostic accuracy than traditional cardiac markers for the early detection of acute myocardial infarction in patients presenting within 4 hours of symptom onset.
Answers are grounded in this paper and cite their sources.
May support early AMI detection in ER within 4 h; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: Although electrocardiography and cardiac troponin play important roles in the diagnosis of acute coronary syndrome (ACS), there remain unmet clinical needs. Heart-type fatty acid-binding protein (H-FABP) has been identified as an early diagnostic marker of acute myocardial infarction (AMI). In this study, we examined the diagnostic and prognostic value of H-FABP in patients suspected with ACS. METHODS: We conducted an observational single-center cohort study, including 89 adults aged 30 years or older, who presented to the emergency room (ER) within 24 hours after the onset of chest pain and/or dyspnea. We performed laboratory analysis and point-of-care testing (POCT) for cardiac markers, including H-FABP, troponin I, and creatine kinase-myocardial band. We also evaluated the correlation between cardiac markers and left ventricular (LV) dysfunction and extent of coronary artery disease (CAD). RESULTS: In patients presented to ER within 4 hours after symptom onset (n = 49), the diagnostic accuracy of H-FABP for AMI, as quantified by the area under the receiver operating characteristic curve, was higher (0.738; 95% confidence interval [CI], 0.591-0.885) than other cardiac markers. In POCT, the diagnostic accuracy of H-FABP (56%; 95% CI, 45-67) was significantly higher than other cardiac markers. H-FABP was correlated with not extent of CAD but post-AMI LV dysfunction. CONCLUSION: H-FABP is a useful cardiac marker for the early diagnosis of AMI and prediction of myocardia injury. Difference in the circulatory release timeline of cardiac markers could explain its utility in early-stage of myocardial injury.
No takes yet. Share an insight, caveat, or question.
Moon et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: